Menlo Park, CA · Founded 2018 · Privately Held (backing)
Developer of engineered cytokine therapeutics designed to facilitate disease-optimized treatments. Synthekine is based in Menlo Park, CA and was founded in 2018. Its last reported valuation was $500 million in Dec 2022. It has raised $289 million.
Last reported valuation
$500.0M
Oct 2026
Priced at
—
Total raised
$288.6M
Last round
—
Team — not yet on record
No current team members for Synthekine are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Synthekine with a free account
·The complete investor list: 13 names
·Watch Synthekine: the Monday email on marks, rounds and moves
